324 related articles for article (PubMed ID: 15871305)
1. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study.
Marcellini M; Di Ciommo V; Callea F; Devito R; Comparcola D; Sartorelli MR; Carelli G; Nobili V
J Lab Clin Med; 2005 Mar; 145(3):139-43. PubMed ID: 15871305
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
[TBL] [Abstract][Full Text] [Related]
3. Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
Cope-Yokoyama S; Finegold MJ; Sturniolo GC; Kim K; Mescoli C; Rugge M; Medici V
World J Gastroenterol; 2010 Mar; 16(12):1487-94. PubMed ID: 20333789
[TBL] [Abstract][Full Text] [Related]
4. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
5. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
6. Serum transaminases in children with Wilson's disease.
Iorio R; D'Ambrosi M; Marcellini M; Barbera C; Maggiore G; Zancan L; Giacchino R; Vajro P; Marazzi MG; Francavilla R; Michielutti F; Resti M; Frediani T; Pastore M; Mazzarella G; Fusco G; Cirillo F; Vegnente A;
J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):331-6. PubMed ID: 15448420
[TBL] [Abstract][Full Text] [Related]
7. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
[TBL] [Abstract][Full Text] [Related]
8. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
9. Wilson's disease: an analysis of 28 Brazilian children.
Kleine RT; Mendes R; Pugliese R; Miura I; Danesi V; Porta G
Clinics (Sao Paulo); 2012; 67(3):231-5. PubMed ID: 22473403
[TBL] [Abstract][Full Text] [Related]
10. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
Brewer GJ; Dick RD; Johnson VD; Brunberg JA; Kluin KJ; Fink JK
J Lab Clin Med; 1998 Oct; 132(4):264-78. PubMed ID: 9794697
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease.
Wu ZY; Lin MT; Murong SX; Wang N
Arch Neurol; 2003 May; 60(5):737-41. PubMed ID: 12756138
[TBL] [Abstract][Full Text] [Related]
13. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
14. Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease.
Mizuochi T; Kimura A; Shimizu N; Nishiura H; Matsushita M; Yoshino M
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):365-7. PubMed ID: 21970993
[TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value and limits of diagnostic parameters for Wilson's disease].
Yang X
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):881-885. PubMed ID: 29325287
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and therapeutic response in Taiwanese children with Wilson's disease: 12 years of experience in a single center.
Wang LC; Wang JD; Tsai CR; Cheng SB; Lin CC
Pediatr Neonatol; 2010 Apr; 51(2):124-9. PubMed ID: 20417464
[TBL] [Abstract][Full Text] [Related]
17. Wilson's disease: presymptomatic patients and Kayser-Fleischer rings.
Rodman R; Burnstine M; Esmaeli B; Sugar A; Martonyi C; Johnson V; Brewer G
Ophthalmic Genet; 1997 Jun; 18(2):79-85. PubMed ID: 9228244
[TBL] [Abstract][Full Text] [Related]
18. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Dzieżyc K; Karliński M; Litwin T; Członkowska A
Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
[TBL] [Abstract][Full Text] [Related]
19. Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience.
Sini M; Sorbello O; Sanna F; Battolu F; Civolani A; Fanni D; Faa G; Demelia L
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):111-7. PubMed ID: 23011036
[TBL] [Abstract][Full Text] [Related]
20. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
Mayet IY
Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
